NeuroVision Monitoring for Spinal Surgery Safety
Trial Summary
What is the purpose of this trial?
The purpose of this study is to perform a prospective, randomized, controlled clinical trial to assess the utility of IONM in patients undergoing primary, single or multilevel lateral spinal procedures. Subjects will be randomized to undergo a lateral spine surgery with the use of NeuroVision® IONM or conventional hospital based IONM to assess incidence of new-onset neurological injury.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment NeuroVision Monitoring for Spinal Surgery Safety?
Intraoperative neurophysiological monitoring (IONM) is shown to be valuable for detecting and preventing nerve damage during spine surgery, improving surgical outcomes, and serving as a safety measure. It is considered the standard of care in many places, providing a safety net to prevent or minimize nerve damage during complex spinal surgeries.12345
Is NeuroVision Monitoring for Spinal Surgery generally safe for humans?
Intraoperative neurophysiological monitoring (IONM), including NeuroVision Monitoring, is widely used during surgeries to help prevent nerve damage by monitoring nerve function in real time. It is considered a standard and safe practice in many surgical procedures, including spinal surgeries, to improve safety and outcomes.23678
How is NeuroVision Monitoring for Spinal Surgery Safety different from other treatments?
NeuroVision Monitoring, or intraoperative neurophysiological monitoring (IONM), is unique because it uses a combination of neurophysiological tests to monitor the spinal cord and nerve function during surgery, helping to prevent nerve damage by providing real-time feedback to the surgical team. This approach is particularly valuable in complex spinal surgeries, as it allows for early detection of potential issues, which can improve surgical outcomes and reduce the risk of postoperative complications.12359
Eligibility Criteria
This trial is for patients who can consent and are having their first single or multilevel lateral spinal surgery due to conditions like myelopathy, radiculopathy, stenosis, herniated discs, degenerative disc disease, spondylosis. It's not for those with recent spinal trauma, active infections or a history of cancer.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo lateral spinal surgery with either NeuroVision® IONM or conventional hospital-based IONM
Immediate Post-operative Monitoring
Participants are monitored for false positive and false negative events in IONM modalities
Follow-up
Participants are monitored for adverse events and new-onset neurological injury
Long-term Follow-up
Participants are assessed for incidence of new-onset neurological injury
Treatment Details
Interventions
- Hospital Based IONM
- NeuroVision® IONM
Hospital Based IONM is already approved in European Union, United States for the following indications:
- Spinal deformity correction
- Spinal tumor resection
- High-grade spondylolisthesis reduction
- Spinal deformity correction
- Spinal tumor resection
- Complex spinal procedures
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rush University Medical Center
Lead Sponsor